Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP780610.RAfwNKDtSoj7JK7kOM5GOTwc57YIZMWqvP00a-Zygef88130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP780610.RAfwNKDtSoj7JK7kOM5GOTwc57YIZMWqvP00a-Zygef88130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP780610.RAfwNKDtSoj7JK7kOM5GOTwc57YIZMWqvP00a-Zygef88130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP780610.RAfwNKDtSoj7JK7kOM5GOTwc57YIZMWqvP00a-Zygef88130_provenance.
- NP780610.RAfwNKDtSoj7JK7kOM5GOTwc57YIZMWqvP00a-Zygef88130_assertion description "[To evaluate the impact of SERCA2a overexpression on SR Ca2+ handling in diabetic CM, we 1) generated transgenic rats harboring a human cytomegalovirus enhancer/chicken beta-actin promotor-controlled rat SERCA2 transgene (SERCA2-TGR), 2) characterized their SR phenotype, and 3) examined whether transgene expression may rescue SR Ca2+ transport in streptozotocin-induced diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP780610.RAfwNKDtSoj7JK7kOM5GOTwc57YIZMWqvP00a-Zygef88130_provenance.
- NP780610.RAfwNKDtSoj7JK7kOM5GOTwc57YIZMWqvP00a-Zygef88130_assertion evidence source_evidence_literature NP780610.RAfwNKDtSoj7JK7kOM5GOTwc57YIZMWqvP00a-Zygef88130_provenance.
- NP780610.RAfwNKDtSoj7JK7kOM5GOTwc57YIZMWqvP00a-Zygef88130_assertion SIO_000772 12206992 NP780610.RAfwNKDtSoj7JK7kOM5GOTwc57YIZMWqvP00a-Zygef88130_provenance.
- NP780610.RAfwNKDtSoj7JK7kOM5GOTwc57YIZMWqvP00a-Zygef88130_assertion wasDerivedFrom befree-20140225 NP780610.RAfwNKDtSoj7JK7kOM5GOTwc57YIZMWqvP00a-Zygef88130_provenance.
- NP780610.RAfwNKDtSoj7JK7kOM5GOTwc57YIZMWqvP00a-Zygef88130_assertion wasGeneratedBy ECO_0000203 NP780610.RAfwNKDtSoj7JK7kOM5GOTwc57YIZMWqvP00a-Zygef88130_provenance.
- befree-20140225 importedOn "2014-02-25" NP780610.RAfwNKDtSoj7JK7kOM5GOTwc57YIZMWqvP00a-Zygef88130_provenance.